Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Prophylactic mastectomy: an appraisal.

Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC.

Am Surg. 2013 Feb;79(2):205-12. Review.

PMID:
23336662
2.

Prophylactic surgery for women at high risk for breast cancer.

Blanchard DK, Hartmann LC.

Clin Breast Cancer. 2000 Jul;1(2):127-34; discussion 135. Review.

PMID:
11899651
3.

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

Contant CM, Menke-Pluijmers MB, Seynaeve C, Meijers-Heijboer EJ, Klijn JG, Verhoog LC, Tjong Joe Wai R, Eggermont AM, van Geel AN.

Eur J Surg Oncol. 2002 Sep;28(6):627-32.

PMID:
12359199
4.

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, van Geel AN, Tilanus MM, Bartels CC, Verhoog LC, Brekelmans CT, Burger CW, Niermeijer MF.

Breast Cancer Res Treat. 2002 May;73(2):97-112.

PMID:
12088120
5.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.

J Clin Oncol. 2004 Mar 15;22(6):1055-62. Epub 2004 Feb 23.

6.

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB.

J Natl Cancer Inst. 2001 Nov 7;93(21):1633-7.

7.

[Surgical prevention of breast carcinoma in patients with hereditary risk].

Dražan L, Veselý J, Hýža P, Kubek T, Foretová L, Coufal O.

Klin Onkol. 2012;25 Suppl:S78-83. Czech.

PMID:
22920212
8.

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Burness ML, Olopade OI.

J Clin Oncol. 2011 May 1;29(13):1652-4. doi: 10.1200/JCO.2010.32.5274. Epub 2011 Mar 28. No abstract available.

9.

Prophylactic mastectomy: indications, options, and reconstructive alternatives.

Spear SL, Carter ME, Schwarz K.

Plast Reconstr Surg. 2005 Mar;115(3):891-909. Review.

PMID:
15731693
10.

Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.

Bresser PJ, Seynaeve C, Van Gool AR, Brekelmans CT, Meijers-Heijboer H, van Geel AN, Menke-Pluijmers MB, Duivenvoorden HJ, Klijn JG, Tibben A.

Plast Reconstr Surg. 2006 May;117(6):1675-82; discussion 1683-4.

PMID:
16651934
11.

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.

Clin Breast Cancer. 2007 Dec;7(11):875-82. doi: 10.3816/CBC.2007.n.053.

PMID:
18269778
12.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.

J Clin Oncol. 2003 May 1;21(9):1675-81.

PMID:
12721241
13.

Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.

Metcalfe KA, Narod SA.

J Natl Cancer Inst. 2002 Oct 16;94(20):1564-9.

14.

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.

Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR.

Ann Intern Med. 2006 Mar 21;144(6):397-406.

PMID:
16549852
15.

Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.

van Dijk S, van Roosmalen MS, Otten W, Stalmeier PF.

J Clin Oncol. 2008 May 10;26(14):2358-63. doi: 10.1200/JCO.2006.10.5494.

16.

Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.

Dowdy SC, Stefanek M, Hartmann LC.

Am J Obstet Gynecol. 2004 Oct;191(4):1113-23.

PMID:
15507929
17.

Prophylactic mastectomy: why and when?

von Smitten K.

J Br Menopause Soc. 2003 Dec;9(4):151-5. Review.

PMID:
15107257
18.

Management of the BRCA mutation carrier or high-risk patient.

Bordeleau LJ, Lipa JE, Neligan PC.

Clin Plast Surg. 2007 Jan;34(1):15-27; abstract v. Review.

PMID:
17307068
19.

Prophylactic mastectomy and genetic testing: an update.

Houshmand SL, Campbell CT, Briggs SE, McFadden AW, Al-Tweigeri T.

Oncol Nurs Forum. 2000 Nov-Dec;27(10):1537-47; quiz 1548-9. Review.

PMID:
11103373
20.

[Prophylactic mastectomies and immediate breast reconstruction in patients at very high genetic risk: our experience with 14 cases].

Missana MC, Chompret A.

Ann Chir Plast Esthet. 2008 Aug;53(4):325-33. Epub 2007 Dec 4. French.

PMID:
18055089
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk